Arcus Biosciences, Inc. RCUS

24.97 (0.09) (0.36%) as of 25 Sep
Market cap
$3.2B
P/E
0.0×

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Net Income

+8 more TTM periods

(341.00) (353.00) (369.00) (460.00)
Depreciation & Amortization
(6.00) (3.00) (3.00) —
Non Cash Items (Other)
72.00 68.00 72.00 74.00
Accounts Receivable Change
5.00 9.00 12.00 9.00
Accounts Payable Change
29.00 24.00 18.00 5.00
Change in other assets and liabilities
(221.00) (227.00) (218.00) (101.00)
Operating Cash Flow
(462.00) (482.00) (488.00) (474.00)
Capital expenditures
(2.00) (2.00) — —
Short Term Investments Change (Net)
210.00 (3.00) 97.00 46.00
Long-Term Investments Change (Net)
91.00 71.00 52.00 18.00
Investing cash flow
299.00 66.00 148.00 63.00
Equity Repurchase (Common, Net)
156.00 439.00 300.00 313.00
Other financial activities
90.00 44.00 — —
Financing cash flow
200.00 488.00 349.00 313.00
Change in Cash
37.00 72.00 9.00 (98.00)
Beginning Cash
153.00 153.00 225.00 225.00
Ending Cash
190.00 225.00 234.00 127.00
Stock Based Compensation
62.00 60.00 63.00 63.00
Dividends Paid (Common)
0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(187.00) (194.00) (188.00) (87.00)
Investments Change (Net)
301.00 68.00 149.00 64.00
Issuance/Purchase of Shares
156.00 439.00 300.00 313.00

Fold the line items

In millions of $ except per-share values · columns are period end dates